Streptococcus salivarius BLIS M18 and Reduced Upper Respiratory Tract Infection Symptoms

• Efficacy of Streptococcus salivarius Blis K12 in the Prevention of Upper Respiratory Tract Infections in Physically Active Individuals: A Randomized Controlled Trial.

  • 2024-10-26
  • RCT · n = 112
  • Microorganisms 12(11)
  • • Alexander Bertuccioli
    • Marco Cardinali
    • Matteo Micucci
    • Marco Bruno Luigi Rocchi
    • Chiara Maria Palazzi
    • Giordano Bruno Zonzini
    • Giosuè Annibalini
    • Annalisa Belli
    • Davide Sisti

  • PubMed: 39597553
  • DOI: 10.3390/microorganisms12112164

  2 Insights on

  • Reduced Upper Respiratory Tract Infection Symptoms

  • High evidence

  higher adherence to the <i>S. salivarius</i> K12 treatment was associated with an increased number of days without URTI symptoms... those with high adherence to <i>S. salivarius</i> K12 (greater than 90%) reported more days free from illness

  Effect

  Beneficial

  Effect size

  Small